Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100. (Q45885454)

17 December 2017

title

Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100. (English)

1 reference

17 December 2017

1 reference

Xia DJ

1

1 reference

17 December 2017

Zhang WP

2

1 reference

17 December 2017

Zheng S

3

1 reference

17 December 2017

Wang J

4

1 reference

17 December 2017

Pan JP

5

1 reference

17 December 2017

Wang Q

6

1 reference

17 December 2017

Zhang LH

7

1 reference

17 December 2017

Hamada H

8

1 reference

17 December 2017

Cao X

9

1 reference

17 December 2017

publication date

1 May 2002

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

592-601

1 reference

17 December 2017

Dendritic cells in cancer immunotherapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Gene-modified dendritic cells for use in tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Human chemokines: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

The makings of a tumor rejection antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Migratory response of human natural killer cells to lymphotactin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Combined chemokine and cytokine gene transfer enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301694

1 reference

17 December 2017

Dimensions Publication ID

1029250173

0 references

1 reference

17 December 2017